Vitae Pharmaceuticals to Present at JMP Securities Life Sciences Conference
June 16, 2015 16:30 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., June 16, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical-stage biotechnology company developing a robust and growing portfolio generated by its...
Vitae Pharmaceuticals to Present at UBS Global Healthcare Conference
May 13, 2015 16:30 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., May 13, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical-stage biotechnology company developing a robust and growing portfolio generated by its...
Vitae Pharmaceuticals Reports First Quarter 2015 Operating and Financial Results
May 12, 2015 16:05 ET
|
Vitae Pharmaceuticals, Inc.
Multiple impending 2Q inflection points supported by enhanced cash position
Conference call scheduled for 4:30 p.m. EDT today
FORT WASHINGTON, Pa., May 12, 2015 (GLOBE NEWSWIRE) -- Vitae...
Vitae Pharmaceuticals to Present at Upcoming Meetings
May 06, 2015 07:30 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., May 6, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical-stage biotechnology company developing a robust and growing portfolio generated by its...
Vitae Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 12, 2015
May 05, 2015 16:30 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., May 5, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical-stage biotechnology company, will host a conference call on Tuesday, May 12, 2015 at 4:30...
Vitae Pharmaceuticals to Present at Keystone Symposia on Mechanisms of Pro-Inflammatory Diseases
April 16, 2015 07:00 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., April 16, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical-stage biotechnology company, today announced that Gerard M. McGeehan, Ph.D., Vice...
Vitae Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Operating and Financial Results
March 31, 2015 07:00 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., March 31, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical-stage biotechnology company, reported today its operating and financial results for the...
Vitae Pharmaceuticals to Announce Fourth Quarter and Full Year 2014 Financial Results on March 31, 2015
March 27, 2015 16:45 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., March 27, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical-stage biotechnology company, will host a conference call on Tuesday, March 31, 2015 at...
Vitae Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference
February 27, 2015 07:30 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., Feb. 27, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical-stage biotechnology company, today announced that Jeffrey Hatfield, President and Chief...
BACE Inhibitor BI 1181181 Voluntarily Put on Temporary Clinical Hold for Safety Evaluation
February 26, 2015 16:10 ET
|
Vitae Pharmaceuticals, Inc.
FORT WASHINGTON, Pa., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc. (Nasdaq:VTAE), a clinical-stage biotechnology company, today announced that its partner Boehringer Ingelheim has...